These findings suggest that TFEB is a promising therapeutic drug candidate for ischemic stroke (Table 1) [100, 103, 104, 164, 182-186, 189-191, 193, 197, 198, 204, 210-216]. The gene discussed is TFEB; the disease is ischemic stroke.